Opportunity overview
Supply of ixekizumab for new patients treated in NHS Scotland
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Eli Lilly and Company
Matched by normalised name
- Contract value
- £1.1m
- Awarded
- Not supplied
- Contract signed
- 27 Apr 2025
- Award ID
- 017857-2025-1
- Status
- active
- Location
- Basingstoke, UK, RG21 4FA, United Kingdom
Classification
- CPV33600000 — Pharmaceutical products
Lots
- Supply of Ixekizumab (Taltz®) to NHS Scotland. The Authority has awarded this framework as a single supplier framework agreement to one (1) Framework Participant.Value not stated